Summary of Study ST001383
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000947. The data can be accessed directly via it's Project DOI: 10.21228/M88T2D This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
Study ID | ST001383 |
Study Title | Investigating exposures and health impacts of endocrine disrupting chemicals among inner-city children. |
Study Type | Observational study |
Study Summary | Our CHEAR project will conduct untargeted metabolomics analyses among children with and without asthma to gain insight into potential mechanisms related to asthma development. Metabolomics analysis will be conducted in a subset of participants from DISCOVER, a panel study enriched with low-income African American children in Baltimore, MD enrolled from 2009 to 2013. We will conduct untargeted metabolomics in serum collected from 15 children with non-atopic asthma and 22 non-atopic children without asthma. For each child, we will conduct analyses in two serum samples collected 3-9 months apart (total = 74 samples). We will use these pilot data to explore differences in metabolomic profiles among non-atopic children with asthma compared to non-asthmatic controls, and leverage repeated sample measures to assess differences in metabolomic profiles among asthmatic children by symptom frequency or severity. Finally, these data will be used to explore differences in metabolomic profiles by exposure status after urinary organophosphate flame retardant biomarkers have been quantified by CHEAR. Together, these analyses will provide pilot data for future work in our Center to assess potential mechanisms related to asthma development and severity as well as effects of organophoshate flame retardant exposures. |
Institute | University of Michigan |
Department | Biomedical Research Core Facilities |
Laboratory | Metabolomics core |
Last Name | Kachman |
First Name | Maureen |
Address | Ann Arbor, MI |
mkachman@med.umich.edu | |
Phone | 734-232-0842 |
Submit Date | 2020-03-18 |
Raw Data Available | Yes |
Raw Data File Type(s) | d |
Chear Study | Yes |
Analysis Type Detail | LC-MS |
Release Date | 2021-08-31 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
Project ID: | PR000947 |
Project DOI: | doi: 10.21228/M88T2D |
Project Title: | Health impacts of endocrine disrupting chemicals |
Project Type: | Observational study |
Project Summary: | Investigating exposures and health impacts of endocrine disrupting chemicals among inner-city children. |
Institute: | University of Michigan |
Department: | Nutritional Sciences |
Laboratory: | Meeker Lab |
Last Name: | Meeker |
First Name: | John |
Address: | Ann Arbor, MI |
Email: | meekerj@umich.edu |
Phone: | 734-764-7184 |
Subject:
Subject ID: | SU001457 |
Subject Type: | Human |
Subject Species: | Homo sapiens |
Taxonomy ID: | 9606 |
Factors:
Subject type: Human; Subject species: Homo sapiens (Factor headings shown in green)
mb_sample_id | local_sample_id | Gender | Condition |
---|---|---|---|
SA100979 | R00CHRPL1-3 | CHEAR | CHEAR |
SA100980 | R00CHRPL1-2 | CHEAR | CHEAR |
SA100981 | R00CHRPL1-4 | CHEAR | CHEAR |
SA100982 | R00CHRPL1-1 | CHEAR | CHEAR |
SA100983 | C-1NYP2-S-00 | Female | asthmatic |
SA100984 | C-1NYQ0-S-00 | Female | asthmatic |
SA100985 | C-1NYR8-S-00 | Female | asthmatic |
SA100986 | C-1NYJ5-S-00 | Female | asthmatic |
SA100987 | C-1NYK3-S-00 | Female | asthmatic |
SA100988 | C-1NYU1-S-00 | Female | asthmatic |
SA100989 | C-1NY93-S-00 | Female | asthmatic |
SA100990 | C-1NY44-S-00 | Female | asthmatic |
SA100991 | C-1NYX4-S-00 | Female | asthmatic |
SA100992 | C-1NZ76-S-00 | Female | asthmatic |
SA100993 | C-1NZ68-S-00 | Female | asthmatic |
SA100994 | C-1NY51-S-00 | Female | asthmatic |
SA100995 | C-1NYW7-S-00 | Female | asthmatic |
SA100996 | C-1NYN6-S-00 | Female | asthmatic |
SA100997 | C-1NY85-S-00 | Female | asthmatic |
SA100998 | C-1NYV9-S-00 | Female | asthmatic |
SA100999 | C-1P025-S-00 | Female | control |
SA101000 | C-1P017-S-00 | Female | control |
SA101001 | C-1NZD7-S-00 | Female | control |
SA101002 | C-1NZN5-S-00 | Female | control |
SA101003 | C-1NZM8-S-00 | Female | control |
SA101004 | C-1NZP1-S-00 | Female | control |
SA101005 | C-1NZS4-S-00 | Female | control |
SA101006 | C-1NZT2-S-00 | Female | control |
SA101007 | C-1NZL0-S-00 | Female | control |
SA101008 | C-1NZK2-S-00 | Female | control |
SA101009 | C-1NZ50-S-00 | Female | control |
SA101010 | C-1NZG1-S-00 | Female | control |
SA101011 | C-1NZH9-S-00 | Female | control |
SA101012 | C-1NZJ4-S-00 | Female | control |
SA101013 | C-1NZC0-S-00 | Female | control |
SA101014 | C-1NYT3-S-00 | Female | control |
SA101015 | C-1NYF4-S-00 | Female | control |
SA101016 | C-1NZ43-S-00 | Female | control |
SA101017 | C-1NYS5-S-00 | Female | control |
SA101018 | C-1NYE6-S-00 | Female | control |
SA101019 | C-1NY77-S-00 | Male | asthmatic |
SA101020 | C-1NYA5-S-00 | Male | asthmatic |
SA101021 | C-1NYB3-S-00 | Male | asthmatic |
SA101022 | C-1NY69-S-00 | Male | asthmatic |
SA101023 | C-1NY36-S-00 | Male | asthmatic |
SA101024 | C-1NXY3-S-00 | Male | asthmatic |
SA101025 | C-1NY28-S-00 | Male | asthmatic |
SA101026 | C-1NYD8-S-00 | Male | asthmatic |
SA101027 | C-1NYC1-S-00 | Male | asthmatic |
SA101028 | C-1NXX5-S-00 | Male | asthmatic |
SA101029 | C-1P009-S-00 | Male | asthmatic |
SA101030 | C-1NZY1-S-00 | Male | asthmatic |
SA101031 | C-1NZW6-S-00 | Male | control |
SA101032 | C-1P033-S-00 | Male | control |
SA101033 | C-1NZX3-S-00 | Male | control |
SA101034 | C-1P058-S-00 | Male | control |
SA101035 | C-1P041-S-00 | Male | control |
SA101036 | C-1NZV8-S-00 | Male | control |
SA101037 | C-1P066-S-00 | Male | control |
SA101038 | C-1NZB2-S-00 | Male | control |
SA101039 | C-1NYL1-S-00 | Male | control |
SA101040 | C-1NYM9-S-00 | Male | control |
SA101041 | C-1NZ27-S-00 | Male | control |
SA101042 | C-1NZU0-S-00 | Male | control |
SA101043 | C-1NYG2-S-00 | Male | control |
SA101044 | C-1NY02-S-00 | Male | control |
SA101045 | C-1NY10-S-00 | Male | control |
SA101046 | C-1NZ35-S-00 | Male | control |
SA101047 | C-1NYH0-S-00 | Male | control |
SA101048 | C-1NZR7-S-00 | Male | control |
SA101049 | C-1NZ84-S-00 | Male | control |
SA101050 | C-1NZF3-S-00 | Male | control |
SA101051 | C-1NZQ9-S-00 | Male | control |
SA101052 | C-1NZ92-S-00 | Male | control |
SA101053 | C-1NZE5-S-00 | Male | control |
SA101054 | C-1NZA4-S-00 | Male | control |
SA101055 | Master pool-08 | POOL | POOL |
SA101056 | Master pool-09 | POOL | POOL |
SA101057 | Master pool-10 | POOL | POOL |
SA101058 | Master pool-07 | POOL | POOL |
SA101059 | Master pool-03 | POOL | POOL |
SA101060 | Master pool-01 | POOL | POOL |
SA101061 | Master pool-02 | POOL | POOL |
SA101062 | Master pool-04 | POOL | POOL |
SA101063 | Master pool-05 | POOL | POOL |
SA101064 | Master pool-06 | POOL | POOL |
Showing results 1 to 86 of 86 |
Collection:
Collection ID: | CO001452 |
Collection Summary: | Standard blood serum collection protocol |
Sample Type: | Blood (serum) |
Storage Conditions: | -80℃ |
Treatment:
Treatment ID: | TR001472 |
Treatment Summary: | This is observational study |
Sample Preparation:
Sampleprep ID: | SP001465 |
Sampleprep Summary: | Standard untargeted metabolomics sample preparation (see enclosed protocol) |
Combined analysis:
Analysis ID | AN002304 | AN002305 | AN002306 | AN002307 |
---|---|---|---|---|
Analysis type | MS | MS | MS | MS |
Chromatography type | Reversed phase | Reversed phase | Reversed phase | Reversed phase |
Chromatography system | Agilent 1290 Infinity II | Agilent 1290 Infinity II | Agilent 1290 Infinity II | Agilent 1290 Infinity II |
Column | Waters Acquity BEH HSS T3 (100 x 2.1mm,1.8um) | Waters Acquity BEH HSS T3 (100 x 2.1mm,1.8um) | Waters Acquity BEH HSS T3 (100 x 2.1mm,1.8um) | Waters Acquity BEH HSS T3 (100 x 2.1mm,1.8um) |
MS Type | ESI | ESI | ESI | ESI |
MS instrument type | QTOF | QTOF | QTOF | QTOF |
MS instrument name | Agilent 6540 QTOF | Agilent 6540 QTOF | Agilent 6540 QTOF | Agilent 6540 QTOF |
Ion Mode | POSITIVE | NEGATIVE | POSITIVE | NEGATIVE |
Units | Peak area normalized | Peak area normalized | Peak area normalized | Peak area normalized |
Chromatography:
Chromatography ID: | CH001693 |
Chromatography Summary: | RP-LCMS-Positive |
Instrument Name: | Agilent 1290 Infinity II |
Column Name: | Waters Acquity BEH HSS T3 (100 x 2.1mm,1.8um) |
Chromatography Type: | Reversed phase |
Chromatography ID: | CH001694 |
Chromatography Summary: | RP-LCMS-Negative |
Instrument Name: | Agilent 1290 Infinity II |
Column Name: | Waters Acquity BEH HSS T3 (100 x 2.1mm,1.8um) |
Chromatography Type: | Reversed phase |
MS:
MS ID: | MS002147 |
Analysis ID: | AN002304 |
Instrument Name: | Agilent 6540 QTOF |
Instrument Type: | QTOF |
MS Type: | ESI |
MS Comments: | Untargeted recursive search (Agilent Qual/MPP/In-house software) |
Ion Mode: | POSITIVE |
MS ID: | MS002148 |
Analysis ID: | AN002305 |
Instrument Name: | Agilent 6540 QTOF |
Instrument Type: | QTOF |
MS Type: | ESI |
MS Comments: | Untargeted recursive search (Agilent Qual/MPP/In-house software) |
Ion Mode: | NEGATIVE |
MS ID: | MS002149 |
Analysis ID: | AN002306 |
Instrument Name: | Agilent 6540 QTOF |
Instrument Type: | QTOF |
MS Type: | ESI |
MS Comments: | Targeted search (Agilent ProFinder) |
Ion Mode: | POSITIVE |
MS ID: | MS002150 |
Analysis ID: | AN002307 |
Instrument Name: | Agilent 6540 QTOF |
Instrument Type: | QTOF |
MS Type: | ESI |
MS Comments: | Targeted search (Agilent ProFinder) |
Ion Mode: | NEGATIVE |